ELAN FY 2019 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.1B+0.1% YoY

Gross Profit

$1.4B45.6% margin

Operating Income

$370M12.0% margin

Net Income

$68M2.2% margin

EPS (Diluted)

$0.18

Cash Flow

Operating Cash Flow

$224M

Free Cash Flow

$27M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$9.0B

Total Liabilities

$3.4B

Stockholders' Equity

$5.5B

Cash & Equivalents

$334M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.1B	$3.1B	+0.1%
Gross Profit	$1.4B	$1.3B	+8.1%
Operating Income	$370M	$314M	+17.9%
Net Income	$68M	$87M	-21.5%